Aclidinium: A guide to its use in chronic obstructive pulmonary disease in the EU

被引：0
|
作者：
Scott L.J. [1 ]
Lyseng-Williamson K.A. [1 ]
Frampton J.E. [1 ]
机构：
[1] Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore 0754, Auckland
来源：
Drugs & Therapy Perspectives | 2013年 / 29卷 / 2期
关键词：
Chronic Obstructive Pulmonary Disease; Chronic Obstructive Pulmonary Disease Patient; Formoterol; Tiotropium; Major Adverse Cardiovascular Event;
D O I：
10.1007/s40267-013-0014-3
中图分类号：
学科分类号：
摘要：
Inhaled aclidinium (Eklira® Genuair® [EU]; Bretaris® Genuair® [EU]; Tudorza™ Pressair™ [US]) is a long-acting antimuscarinic agent. In the EU, it is indicated as maintenance bronchodilator treatment in patients with chronic obstructive pulmonary disease (COPD). Aclidinium provides improvements in lung function, dyspnoea and disease-specific health status in patients with COPD, and is generally well tolerated. © 2013 Springer International Publishing Switzerland.
引用
收藏
页码：34 / 39
页数：5
相关论文
共 50 条
  • [21] Reduction in clinically important deterioration in chronic obstructive pulmonary disease with aclidinium/formoterol
    Singh, Dave
    D'Urzo, Anthony D.
    Chuecos, Ferran
    Munoz, Anna
    Gil, Esther Garcia
    RESPIRATORY RESEARCH, 2017, 18
  • [22] BUDGET IMPACT ANALYSIS OF ACLIDINIUM BROMIDE IN THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
    Yagudina, R.
    Kulikov, A.
    Makarova, E.
    VALUE IN HEALTH, 2016, 19 (07) : A550 - A550
  • [23] Reduction in clinically important deterioration in chronic obstructive pulmonary disease with aclidinium/formoterol
    Dave Singh
    Anthony D. D’Urzo
    Ferran Chuecos
    Anna Muñoz
    Esther Garcia Gil
    Respiratory Research, 18
  • [24] Aclidinium Bromide Twice Daily for the Treatment of Chronic Obstructive Pulmonary Disease: A Review
    Paul Jones
    Advances in Therapy, 2013, 30 : 354 - 368
  • [25] Aclidinium Bromide Twice Daily for the Treatment of Chronic Obstructive Pulmonary Disease: A Review
    Jones, Paul
    ADVANCES IN THERAPY, 2013, 30 (04) : 354 - 368
  • [26] Aclidinium bromide and formoterol fumarate for the maintenance treatment of chronic obstructive pulmonary disease
    Haley, Ryan
    Gupta, Nita
    Sethi, Sanjay
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2020, 13 (02) : 103 - 113
  • [27] The potential for aclidinium bromide, a new anticholinergic, in the management of chronic obstructive pulmonary disease
    Maltais, Francois
    Milot, Julie
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2012, 6 (06) : 345 - 361
  • [28] Specific role of combination aclidinium: formoterol in the treatment of chronic obstructive pulmonary disease
    Matera, Maria Gabriella
    Sanduzzi, Alessandro
    Cazzola, Mario
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2016, 11 : 73 - 79
  • [29] Olodaterol: A Review of Its Use in Chronic Obstructive Pulmonary Disease
    Deeks, Emma D.
    DRUGS, 2015, 75 (06) : 665 - 673
  • [30] Olodaterol: A Review of Its Use in Chronic Obstructive Pulmonary Disease
    Emma D. Deeks
    Drugs, 2015, 75 : 665 - 673
12345